{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Schaumburg",
      "address_1": "1501 E Woodfield Rd",
      "reason_for_recall": "Crystallization: Active pharmaceutical ingredient is precipitating in product solution.",
      "address_2": "Suite 300 East",
      "product_quantity": "23,672 vials",
      "code_info": "Lot #: 872CZ00101, Exp 12/13",
      "center_classification_date": "20130821",
      "distribution_pattern": "Nationwide",
      "state": "IL",
      "product_description": "IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC,  Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.",
      "report_date": "20130828",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Fresenius Kabi USA LLC (FK USA)",
      "recall_number": "D-915-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "64102",
      "termination_date": "20150512",
      "recall_initiation_date": "20130122",
      "postal_code": "60173-6052",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}